Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ASRA
ESRA
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ASRA
ESRA
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 42, Issue 5
The Case for Thinking Beyond Classic Randomized Controlled Trial Design: A Response to “Distinguishing Between Efficacy and Real-World Effectiveness”
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Letters to the Editor
The Case for Thinking Beyond Classic Randomized Controlled Trial Design: A Response to “Distinguishing Between Efficacy and Real-World Effectiveness”
Online download statistics by month:
Online download statistics by month: May 2019 to August 2022
Abstract
Full
Pdf
May 2019
0
0
1
Aug 2019
0
0
1
Oct 2019
0
0
1
Oct 2020
0
0
1
Feb 2021
0
0
3
Aug 2022
0
0
1
Total
0
0
8
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ASRA
ESRA
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF